Latest Governance News

Santos Limited’s 2024 Annual Report reveals a 5% decline in production and a 9% drop in sales revenue, yet highlights significant progress in carbon capture and storage projects and emissions reduction targets.

Santos Limited's 2024 Annual Report reveals a 5% drop in production and a 9% fall in sales revenue, yet highlights significant progress in carbon capture and storage and emissions reduction efforts. The company remains committed to its net-zero targets and sustainable growth strategy.

Santos Limited's 2024 Annual Report reveals a 5% drop in production and a 9% decline in sales revenue, yet highlights progress in carbon capture and storage and emissions reduction. The company maintains a strong balance sheet while advancing its Climate Transition Action Plan.

Santos Limited's 2024 Annual Report reveals a 5% drop in production and a 9% decline in sales revenue, yet highlights significant progress in carbon capture and storage projects and emissions reduction targets.

Santos Limited's 2024 Annual Report reveals a 5% drop in production and a 9% fall in sales revenue, yet the company maintains strong profitability and advances key climate initiatives including the Moomba CCS project.

Santos Limited’s 2024 Annual Report reveals a 5% drop in production and a 9% decline in sales revenue, yet highlights significant progress in carbon capture and storage projects and emissions reduction targets.

Santos Limited's 2024 Annual Report reveals a 5% drop in production and a 9% decline in sales revenue, yet highlights progress in carbon capture and storage and emissions reduction. The company maintains a strong balance sheet while advancing its Climate Transition Action Plan.

Santos Limited’s 2024 Annual Report reveals a 5% drop in production and a 9% decline in sales revenue, yet the company achieved a net profit of $1.224 billion while making significant strides in carbon capture and storage and emissions reduction.

Renegade Exploration reports significant discoveries of critical defence metals germanium and gallium at its Yukon Andrew Deposit, alongside promising gold-silver prospects, while progressing copper and cobalt projects in Queensland amid a tight cash position.

CAQ Holdings Limited posted a 5% decline in leasing revenue for the March 2025 quarter, while vacancy rates held steady and operating cash flow remained positive despite ongoing regulatory uncertainties in China.

Zenith Minerals reported a pivotal quarter advancing exploration at its Dulcie Far North and Red Mountain gold projects, while agreeing to divest its Turkish Kavaklitepe interest, sharpening its focus on domestic assets.

EVE Health Group has executed a binding agreement to acquire Australian biotech Nextract, targeting rapid-onset treatments in the $16 billion global erectile dysfunction and dysmenorrhea markets. The acquisition, supported by a $1.5 million capital raise and share consolidation, marks a strategic shift into regulated pharmaceutical channels.